retatrutide for diabetes Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA New Kind of Diabetes Drug

Potential for Contamination Over time, the preservative components of the medication may break down, increasing the risk of contamination

CagriSema dosing schedule The CagriSema dosing protocol follows a gradual titration designed to minimize gastrointestinal side effects while reaching the full therapeutic dose

The ideal scenario is that theres a conversation between the patient, the provider whos prescribing this medication, and at least one of the professionals working with the individual on their eating disorder, says Smith

2024 Apr 22

Keeps: 5 days in fridge, 3 months in freezer

Not catastrophic, but worth knowing, especially if your last dose from a vial seems to come up short